Age-related decrease in the hypothalamic CRH mRNA expression is reduced by dehydroepiandrosterone (DHEA) treatment in...

Area of Science:

• Neuroendocrinology
• Aging Research
• Molecular Biology

Background:

• Aging impacts physiological and cognitive functions, notably affecting the hypothalamo-pituitary-adrenocortical (HPA) axis.
• Previous research on aging's influence on the HPA axis presents conflicting findings.
• Clarifying these effects is crucial for understanding age-related health changes.

Purpose of the Study:

• To investigate the effects of aging on the HPA axis by examining hypothalamic corticotropin-releasing hormone (CRH) gene expression.
• To determine the impact of dehydroepiandrosterone (DHEA) treatment on age-related alterations in CRH mRNA levels in both male and female rats.

Main Methods:

• Quantified CRH mRNA expression in the hypothalamic paraventricular nucleus (PVN) of young (50 days) and old (18 months) rats using in situ hybridization.
• Administered dehydroepiandrosterone (DHEA) to assess its effects on CRH mRNA levels in different age groups and sexes.

Main Results:

• Aging significantly reduced CRH mRNA levels in the PVN by 20% in both male and female rats.
• DHEA treatment increased CRH mRNA expression in young rats and fully reversed the age-related decrease in old rats.
• Sex-specific responses to DHEA were observed, with young males and old females showing greater sensitivity.

Conclusions:

• Aging induces a significant decrease in basal CRH mRNA levels in apparently healthy rats.
• DHEA positively influences CRH gene expression and effectively reverses age-associated reductions in CRH mRNA.
• These findings highlight DHEA's potential role in mitigating age-related HPA axis dysregulation.